ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2367

Presence of Fibromyalgia and Fatigue Is Not Increased in Patients with Takayasu’s Arteritis

Fatma Alibaz-Oner1, Meryem Can1, Birkan Ilhan2, Ozge Polat2 and Haner Direskeneli1, 1Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey, 2Internal Medicine, Marmara University, School of Medicine, Istanbul, Turkey

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Takayasu.s arteritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Vasculitis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Takayasu’s arteritis (TAK) is a large-vessel vasculitis of the aorta and its major branches. To our knowledge, no data is reported about the frequency of Fibromyalgia Syndrome (FM), in TAK. We aimed to investigate the frequency of FM in TAK, defined according to the new 2010 ACR Preliminary Diagnostic Criteria for Fibromyalgia. The correlation between ACR-1990 and 2010 FM criterias and the effect of patient-reported outcomes (PROs) such as Health Assessment Questionnaire (HAQ), Multidimensional Assessment of Fatigue Scale (MAF), Short-Form 36-item survey (SF–36) and hospital anxiety and depression scales (HADS) on FM were analyzed.

Methods: We studied 51 patients with TAK (F/M: 47/4, mean age: 42.3 years),  50  (F/M: 35/15, mean age: 40.89 years) healthy controls (HC). All patients were examined for FM tender points by two observers (kappa: 0.648) and asked to complete new ACR 2010 FM questionnaire for FM (ref1). SF–36, MAF and HADS were used to assess quality of life together with HAQ. Seventeen patients were re-evaluated 6 months later.

Results: Six(11,7%) patients with TAK and 5 HC (10%) met the ACR-2010 FM criteria, whereas only 3(5,8%) TAK patients and no controls (0%) met the 1990 Criteria. No significant differences regarding the FM frequency were present according to both ACR-2010 and 1990 FM criterias between TAK and HC. No differences were also observed for the 2 subscales of 2010 criteria, the Widespread Pain Index(WPI) and the Symptom Severity scale(SSS) scale among the groups. Fourteen patients (33,3%) were clinically active. FM presence was also similar between active and inactive patients (p=0,188). The results of PROs were showed in Table 1. WPI correlate significantly with tender points (r=0,477, p<0,001), MAF (r=0,623, p<0,001), HAQ (r=0,477, p<0,001), anxiety (r=0,458, p<0,001), depression (r=0,378, p<0,001), PCS (r=-0,586, p<0,001) and MCS (r=-0, 335, p<0,001). SSS correlate significantly with tender points (r=0,477, p<0,001), MAF (r=0,775, p<0,001), HAQ (r=0,437, p<0,001), anxiety (r=0,557, p<0,001), depression (r=0,438, p<0,001),  PCS (r= -0,593, p<0,001) and MCS (r=-0,531, p<0,001). During follow-up, no significant differences between baseline and 6.month were observed in terms of  frequency of FM, MAF, HAQ,HADS, PCS and MCS.

Table 1:  Results of the patient-reported outcomes in TAK and controls

 

Takayasu’s  arteritis

(n=51)

Healthy controls

(n=50)

P values

MAF

18,5 (0-49,7)

17,5 (0-38,6)

0,282

Anxiety scale score

5 (0-21)

5 (0-18)

0,533

Depression scale score

3 (0-21)

3 (0-14

0,529

HAQ

0,15 (0- 2,35)

0 (0-0,8)

<0,001

PCS                                         

46,9 (17,5-61,7)

53,4 (30,4-100)

0,003

MCS

46 (22,4-65,4)

49,9 (20,8-100)

0,350

Conclusion: The frequency of FM is similar to general population in patients with Takayasu arteritis.  However, although other PROs also does not differ from HC, the new FM criteria subscales WPI and SSS significantly correlated with scales such as SF-36, MAF, anxiety and depression scale and HAQ in TA, suggesting that in a minority of patients with FM and TA, PROs are affected with FM presence.

1. Wolfe F, Clauw DJ, Fitzcharles MA, et all. The ACR preliminary diagnostic criteria forfibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken). 2010 May;62(5):600-10.


Disclosure:

F. Alibaz-Oner,
None;

M. Can,
None;

B. Ilhan,
None;

O. Polat,
None;

H. Direskeneli,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/presence-of-fibromyalgia-and-fatigue-is-not-increased-in-patients-with-takayasus-arteritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology